MGRM logo
MGRM NASDAQ US

Monogram Technologies Inc. - Common Stock

Health Care · Health Care Website · IPO May 2023
$6.00
3
Quality Score
fail
Mkt Cap
$243.8M
ROE
-137.2%
D/E
0.00
Beta
0.65
52W
$2–$6

Wall Street Consensus

7 analysts · Feb 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Earnings

Beat rate: 25.0%
Next Report May 12, 2026
EPS Estimate: $-0.17
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.17
Jun 2025 $-0.11 $-0.16 $-0.05
Mar 2025 $-0.12 $-0.10 +$0.02
Dec 2024 $-0.11 $-0.13 $-0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -137.2% -126.4% -137.2% -137.2% -137.2% -137.2%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 2.16 7.00 2.16 2.16 2.16 2.16

Key Ratios

ROA (TTM)
-104.8%
P/B
5.6
EPS (TTM)
$-0.52
52W High
$6.43
52W Low
$2.11
$2.11 52-Week Range $6.43

How does MGRM compare to Health Care peers?

Peer group: Micro-cap Health Care (All) · 241 companies

MGRM valuation vs Health Care peers

P/E ratio
0% below peers (30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (2.6)
vs Peers
vs Industry
Overvalued
P/B ratio
5.6
102% above peers (2.8)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.7%)
vs Peers
vs Industry
Low yield

MGRM profitability vs Health Care peers

ROE
-137.2%
256% below peers (-38.5%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-24.7%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (52.9%)
vs Peers
vs Industry
Top tier
ROA
-104.8%
394% below peers (-21.2%)
vs Peers
vs Industry
Weak

MGRM financial health vs Health Care peers

D/E ratio
0.0
100% below peers (19.3)
vs Peers
vs Industry
Low debt
Current ratio
2.2
0% above peers (2.2)
vs Peers
vs Industry
In line
Beta
0.7
38% below peers (1.1)
vs Peers
vs Industry
More volatile

MGRM fundamentals radar

MGRM Peer median Industry

MGRM profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MGRM vs peers: key metrics

Latest News

No related news yet